The Effect of a Novel Follow-up Mode Integrating Specialist Nurse-Led Care and an Intelligent Platform on Peritoneal Dialysis Patients
Open Access
- 1 October 2025
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 18, 303-311
Abstract
Purpose: To evaluate the effect of a novel follow-up mode integrating specialist nurse-led care and an intelligent platform on fluid volume management in patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD). Patients and Methods: A pre- and post-observational clinical cohort of 80 PD patients (Shanghai General Hospital South, Mar 2020–Mar 2021) evaluated the 12-month impact of the novel mode on fluid volume overload (FVL), cardiac function, laboratory indicators (including biochemical parameters and electrolytes), and clinically relevant complications (peritonitis, exit-site/tunnel infection and catheter displacement). Results: After 12 months of follow-up using the novel mode, significant improvements were observed compared to the traditional follow-up approach. Specifically, levels of B-type natriuretic peptide (BNP) (144.12± 14.21 vs 631.01± 104.21 pg/mL, P < 0.001), systolic blood pressure (SBP) (136.99± 12.04 vs 145.34± 15.22 mmHg, P < 0.001), and diastolic blood pressure (DBP) (79.03± 6.35 vs 84.87± 8.17 mmHg, P < 0.01) were significantly lower in patients managed with the novel mode. Additionally, blood calcium (2.24± 0.52 vs 2.18± 0.02 pg/mL, P < 0.05), phosphorus (1.96± 0.07 vs 1.80± 0.06 mmol/L, P < 0.01), parathyroid hormone (PTH) (409.28± 43.49 vs 250.84± 23.26 pg/mL, P < 0.001), and albumin (38.89± 0.60 vs 36.25± 0.51 pg/mL, P < 0.001) levels were higher following implementation of the novel mode. FVL and cardiac function also showed significant improvement over the 12-months follow-up period. Notably, compared with the preceding 12-month control period, the platform-based follow-up reduced clinically relevant infectious complications from 10.3% to 3.8% (McNemar mid-p = 0.077). Conclusion: The novel follow-up mode effectively reduced fluid volume overload and improved cardiac function, offering clinical benefits for PD patients.Keywords
This publication has 13 references indexed in Scilit:
- Managing Hospitalized Peritoneal Dialysis Patients: Ten Practical Points for Non-NephrologistsThe American Journal of Medicine, 2021
- ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 Update (paediatrics)Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2021
- Successful Automated Peritoneal Dialysis (APD) in a COVID-19 patient with acalculous pancreatitis with no detectable virus in the dialysate effluentIndian Journal of Medical Microbiology, 2021
- International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysisPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2020
- Volume management as a key dimension of a high-quality PD prescriptionPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2020
- Clinical Implications of the New York Heart Association ClassificationJournal of the American Heart Association, 2019
- Chronic Fluid Overload and Mortality in ESRDJournal of the American Society of Nephrology, 2017
- Prevalence and Risk Factors of Fluid Overload in Southern Chinese Continuous Ambulatory Peritoneal Dialysis PatientsPLOS ONE, 2013
- Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathyCEN Case Reports, 2012
- Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study CohortPLOS ONE, 2011